These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34227209)
21. Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug. Ross CL; Lawer A; Sircombe KJ; Pletzer D; Gamble AB; Hook S J Med Chem; 2024 Jun; 67(11):9599-9612. PubMed ID: 38780408 [TBL] [Abstract][Full Text] [Related]
22. An unexpected amide bond cleavage: poly (ethylene glycol) transport forms of vancomycin. 2. Greenwald RB; Zhao H; Peng P; Longley CB; Dai QH; Xia J; Martinez A Eur J Med Chem; 2005 Aug; 40(8):798-804. PubMed ID: 16122582 [TBL] [Abstract][Full Text] [Related]
23. Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications. Xiao T; Liu K; Huigens RW Bioorg Med Chem Lett; 2020 Nov; 30(22):127515. PubMed ID: 32860978 [TBL] [Abstract][Full Text] [Related]
24. Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct. Dibama HM; Clarot I; Fontanay S; Salem AB; Mourer M; Finance C; Duval RE; Regnouf-de-Vains JB Bioorg Med Chem Lett; 2009 May; 19(10):2679-82. PubMed ID: 19395263 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial peptides with protease stability: progress and perspective. Shao C; Zhu Y; Lai Z; Tan P; Shan A Future Med Chem; 2019 Aug; 11(16):2047-2050. PubMed ID: 31538527 [No Abstract] [Full Text] [Related]
26. Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen. Çelik A; Yetiş G; Ay M; Güngör T Bioorg Med Chem Lett; 2016 Aug; 26(16):4057-60. PubMed ID: 27390065 [TBL] [Abstract][Full Text] [Related]
27. Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates. Boyce JH; Dang B; Ary B; Edmondson Q; Craik CS; DeGrado WF; Seiple IB J Am Chem Soc; 2020 Dec; 142(51):21310-21321. PubMed ID: 33301681 [TBL] [Abstract][Full Text] [Related]
28. A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria. Zhu C; Schneider EK; Wang J; Kempe K; Wilson P; Velkov T; Li J; Davis TP; Whittaker MR; Haddleton DM J Control Release; 2017 Aug; 259():83-91. PubMed ID: 28174100 [TBL] [Abstract][Full Text] [Related]
29. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery. Xu M; Qian J; Liu X; Liu T; Wang H Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279 [TBL] [Abstract][Full Text] [Related]
30. Double-PEGylated Cyclopeptidic Photosensitizer Prodrug Improves Drug Uptake from In Vitro to Hen's Egg Chorioallantoic Membrane Model. Bouilloux J; Kiening M; Yapi S; Lange N Molecules; 2021 Oct; 26(20):. PubMed ID: 34684822 [TBL] [Abstract][Full Text] [Related]
31. Innate glycosidic activity in metallic implants for localized synthesis of antibacterial drugs. Ter Meer M; Dillion R; Nielsen SM; Walther R; Meyer RL; Daamen WF; van den Heuvel LP; van der Vliet JA; Lomme RMLM; Hoogeveen YL; Schultze Kool LJ; Schaffer JE; Zelikin AN Chem Commun (Camb); 2019 Jan; 55(4):443-446. PubMed ID: 30489589 [TBL] [Abstract][Full Text] [Related]
32. Production of Long-Acting CNGRC-CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment. Al-Mansoori L; Al Qahtani AD; Elsinga P; Goda SK Technol Cancer Res Treat; 2021; 20():15330338211057371. PubMed ID: 34802309 [No Abstract] [Full Text] [Related]
33. Liposomes as carriers for colchicine-derived prodrugs: vascular disrupting nanomedicines with tailorable drug release kinetics. Crielaard BJ; van der Wal S; Le HT; Bode AT; Lammers T; Hennink WE; Schiffelers RM; Fens MH; Storm G Eur J Pharm Sci; 2012 Mar; 45(4):429-35. PubMed ID: 21907797 [TBL] [Abstract][Full Text] [Related]
34. Activation of antibacterial prodrugs by peptide deformylase. Wei Y; Pei D Bioorg Med Chem Lett; 2000 May; 10(10):1073-6. PubMed ID: 10843220 [TBL] [Abstract][Full Text] [Related]
35. Insight into Prodrugs of Quinolones and Fluoroquinolones. Sharma PC; Piplani M; Mittal M; Pahwa R Infect Disord Drug Targets; 2016; 16(3):140-161. PubMed ID: 27558786 [TBL] [Abstract][Full Text] [Related]
38. Sequence-Defined Backbone Modifications Regulate Antibacterial Activity of OligoTEAs. Porel M; Thornlow DN; Artim CM; Alabi CA ACS Chem Biol; 2017 Mar; 12(3):715-723. PubMed ID: 28068062 [TBL] [Abstract][Full Text] [Related]
39. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives. Akinboye ES; Rosen MD; Bakare O; Denmeade SR Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549 [TBL] [Abstract][Full Text] [Related]
40. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier. Li M; Liang Z; Sun X; Gong T; Zhang Z PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]